prednisone has been researched along with Lichen Planus, Oral in 15 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Lichen Planus, Oral: Oral lesions accompanying cutaneous lichen planus or often occurring alone. The buccal mucosa, lips, gingivae, floor of the mouth, and palate are usually affected (in a descending order of frequency). Typically, oral lesions consist of radiating white or gray, velvety, threadlike lines, arranged in a reticular pattern, at the intersection of which there may be minute, white, elevated dots or streaks (Wickham's striae). (Jablonski, Illustrated Dictionary of Dentistry)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Responses to treatment and disease progression were determined by comparing scores with baseline scores." | 1.31 | Oral lichen planus: patient profile, disease progression and treatment responses. ( Chainani-Wu, N; Lozada-Nur, F; Mayer, P; Silverman, S; Watson, JJ, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuten-Shorrer, M | 1 |
| Hochberg, EP | 1 |
| Woo, SB | 1 |
| Said-Al-Naief, N | 1 |
| Rosebush, MS | 1 |
| Lynch, D | 1 |
| Ghallab, NA | 1 |
| el-Wakeel, N | 1 |
| Shaker, OG | 1 |
| Kaplan, I | 1 |
| Ventura-Sharabi, Y | 1 |
| Gal, G | 1 |
| Calderon, S | 1 |
| Anavi, Y | 1 |
| Tang, GY | 1 |
| Goñi Esarte, S | 1 |
| Arín Letamendía, A | 1 |
| Vila Costas, JJ | 1 |
| Jiménez Pérez, FJ | 1 |
| Ruiz-Clavijo García, D | 1 |
| Carrascosa Gil, J | 1 |
| Almendral López, ML | 1 |
| Carbone, M | 2 |
| Goss, E | 1 |
| Carrozzo, M | 2 |
| Castellano, S | 2 |
| Conrotto, D | 2 |
| Broccoletti, R | 2 |
| Gandolfo, S | 2 |
| Stoopler, ET | 1 |
| Sollecito, TP | 1 |
| DeRossi, SS | 1 |
| Huber, MA | 1 |
| Cheng, A | 1 |
| Mann, C | 1 |
| Lozada-Nur, F | 2 |
| Miranda, C | 1 |
| Cohen, DM | 1 |
| Bhattacharyya, I | 1 |
| Zunt, SL | 1 |
| Tomich, CE | 1 |
| Buser, D | 1 |
| Meier, E | 1 |
| Magnin, P | 1 |
| Rees, TD | 1 |
| Chainani-Wu, N | 1 |
| Silverman, S | 1 |
| Mayer, P | 1 |
| Watson, JJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Ginger Muco-bioadhesive Gel in Management of Oral Lichen Planus: A Randomized Controlled Clinical Trial With Immunohistochemical Analysis[NCT05882864] | Phase 4 | 28 participants (Anticipated) | Interventional | 2023-08-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisone and Lichen Planus, Oral
| Article | Year |
|---|---|
Oral lichen planus: topical and systemic therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Biopsy; Clinical Protoco | 1997 |
2 trials available for prednisone and Lichen Planus, Oral
| Article | Year |
|---|---|
Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Age | 2003 |
Systemic corticosteroid therapy of oral vesiculoerosive diseases (OVED). An open trial.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Autoimmune Diseases; Erythema Multiforme; Female; | 1998 |
12 other studies available for prednisone and Lichen Planus, Oral
| Article | Year |
|---|---|
Lichenoid mucosal reaction to rituximab.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Dexamethasone; Female; Humans; Lichen Planus | 2014 |
Clinical-pathological conference: case 2.
Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Diagnosis, Differential; Female; Gingivitis, Ne | 2010 |
Levels of salivary IFN-gamma, TNF-alfa, and TNF receptor-2 as prognostic markers in (erosive) oral lichen planus.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Case-Control Studies; Female; Humans; Inflammation Medi | 2010 |
The dynamics of oral lichen planus: a retrospective clinicopathological study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Cell Transformat | 2012 |
[Advance and prospect for the diagnosis and management of lichen planus].
Topics: Antibodies, Monoclonal; Basiliximab; Cell Transformation, Neoplastic; Dexamethasone; Drugs, Chinese | 2012 |
[Rituximab as rescue therapy in refractory esophageal lichen planus].
Topics: Alopecia; Androstadienes; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Atrophy; | 2013 |
Desquamative gingivitis: early presenting symptom of mucocutaneous disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Biopsy; Clobetasol; Dapsone; Diagnosis | 2003 |
Oral lichen planus.
Topics: Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Diagnosis, Differential; Glucocorticoids; | 2004 |
Oral erosive lichen planus treated with efalizumab.
Topics: Administration, Oral; Administration, Topical; Anti-Inflammatory Agents; Antibodies, Monoclonal; Ant | 2006 |
Linear IgA disease histopathologically and clinically masquerading as lichen planus.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatologic Agents; Diagnosis, Differential | 1999 |
[Oral lichen planus. 2. Therapy possibilities and current treatment concepts].
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Inflammatory Agents; Cyclosporins; Female; | 2001 |
Oral lichen planus: patient profile, disease progression and treatment responses.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Carcinoma, Squamous Ce | 2001 |